期刊文献+

炎症性肠病活动期患者肠黏膜白细胞介素-22结合蛋白及细胞因子表达研究 被引量:3

Study on the expression of IL-22 binding protein and cytokines in intestinal mucosa of patients with inflammatory bowel disease in active stage
下载PDF
导出
摘要 目的研究炎症性肠病活动期患者肠黏膜白细胞介素-22结合蛋白(IL-22BP)及细胞因子的表达状况。方法选取2016年6月至2018年6月接诊的65例炎症性肠病患者进行研究。其中克罗恩病组(CD组)30例,溃疡性结肠炎组(UC组)35例。并选取同期接受治疗的结肠息肉患者30例作为对照组,检测分析三组肠黏膜IL-22BP及细胞因子表达水平。结果 CD组及UC组活动期患者的IL-22BP mRNA及蛋白水平均明显高于缓解期患者(P<0.05),且均明显高于对照组(P<0.05)。CD组及UC组活动期患者的IL-6、IL-8及TNF-α水平均明显高于缓解期患者(P<0.05),且均明显高于对照组(P<0.05)。结论炎症性肠病活动期患者肠黏膜IL-22BP及细胞因子表达水平明显升高,检测各项指标有助于预测患者活动期状况,值得临床推广应用。 Objective To study the expression of interleukin-22 binding protein(IL-22 BP) and cytokines in intestinal mucosa of patients with inflammatory bowel disease in active stage.Methods 65 patients with inflammatory bowel disease from June 2016 to June 2018 were selected for the study,with 30 cases in Crohn’s disease group(CD group) and 35 cases in ulcerative colitis group(UC group).At the same time,30 patients with colonic polyps were selected as control group.And then,the expressions of IL-22 BP and cytokines in the intestinal mucosa of the three groups were detected and analyzed.Results The levels of IL-22 BP in the CD group and the UC group in active stage were significantly higher than those in remission stage(P<0.05),and were all significantly higher than those in the control group(P<0.05).In addition,the levels of IL-6,IL-8 and TNF-α in active stage in the CD group and the UC group were significantly higher than those in remission stage(P<0.05),and were all significantly higher than those in the control group(P<0.05).Conclusion The expressions of IL-22 BP and inflammatory cytokines in intestinal mucosa of patients with inflammatory bowel disease in active stage increase significantly.The detection of various indicators is helpful to predict the status of patients in active stage,and it is worth popularizing in clinical practice.
作者 李息友 邱晓敏 曹杰 LI Xiyou;QIU Xiaomin;CAO Jie(Department of Gastroenterology,The Second Affiliated Hospital of Guilin Medical University,Guilin 541199;Department of General Medicine,Guilin University of Aerospace Technology Hospital,Guilin 541004,China)
出处 《右江医学》 2019年第2期98-101,共4页 Chinese Youjiang Medical Journal
关键词 炎症性肠病 活动期 细胞因子 白细胞介素-22结合蛋白 inflammatory bowel disease active stage cytokines IL-22BP
  • 相关文献

参考文献9

二级参考文献84

  • 1柳婧,高翔,陈烨,梅俏,朱良如,韩英,田丰,张虎,张晓岚,缪应雷,于晓峰,施华秀,王承党,刘玉兰,王晓艳,李学锋,钱家鸣,胡品津,曹倩.中国炎症性肠病患者深静脉血栓情况调查:一项全国多中心回顾性研究[J].中华炎性肠病杂志(中英文),2017,1(1):24-28. 被引量:25
  • 2陈白莉,钱家鸣,吴开春,盛剑秋,许建明,冉志华,袁耀宗,王化虹,陈志芬,李兆申,唐承薇,侯晓华,侯妍妍,陈旻湖,胡品津.英夫利西治疗活动性溃疡性结肠炎疗效与安全性的临床研究[J].中华炎性肠病杂志(中英文),2017,1(1):20-23. 被引量:15
  • 3李亚红,韩英,吴开春.炎症性肠病危险因素的流行病学调查研究[J].胃肠病学和肝病学杂志,2006,15(2):161-162. 被引量:19
  • 4Heinsbroek SE, Gordon S. The role of macrophages in inflammatory bowel diseases [ J ]. Expert Rev Mol Med, 2009, 11 : e14.
  • 5Neurath MF. Cytokines in inflammatory bowel disease [ J ]. Nat Rev Immunol, 2014, 14 (5) : 329-342.
  • 6Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease : report of a Working Party of the 2005 Montreal World Congress of Gastroenterology[ J]. Can J Gastroenterol, 2005, 19 Suppl A: 5A-36A.
  • 7Yu Y, Sitaraman S, Gewirtz AT. Intestinal epithelial cell regulation of mucosal inflammation [ J ]. Immunol Res, 2004, 29 (1-3) : 55-68.
  • 8Reimund JM, Wittersheim C, Dumont S, et al. Increased production of tumour necrosis factor-alpha, interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn' s disease[ J]. Gut, 1996, 39 (5): 684-689.
  • 9Kadivar K, Ruchelli ED, Markowitz JE, et al. Intestinal interleukin-13 in pediatric inflammatory bowel disease patients [ J ]. Inflamm Bowel Dis, 2004, 10 (5) : 593 -598.
  • 10Kishirnoto T, Akira S, Taga T. IL-6 receptor and mechanism of signal transduction[ J]. Int J Immunopharmacol, 1992, 14 (3) : 431-438.

共引文献651

同被引文献35

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部